Latest News and Press Releases
Want to stay updated on the latest news?
-
SAINT-GENIS-POUILLY, France, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
-
SAINT-GENIS-POUILLY, France, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
-
SAINT-GENIS-POUILLY, France, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
-
SAINT-GENIS-POUILLY, France, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
-
Highlights: Sales for the second quarter of 2016 increased 24.4% compared to the second quarter of 2015The U.S. Food and Drug Administration (FDA) granted Priority Review for Lutathera, with a...
-
SAINT-GENIS-POUILLY, France, July 26, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
-
Lutathera Expanded Access Program Now Open In U.S. to Eligible Patients NDA Filing to FDA and EMA Forthcoming SAINT-GENIS-POUILLY, France, March 23, 2016 (GLOBE NEWSWIRE) -- Advanced...